Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: A randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial." The Lancet , 402(10404), 529-544
Promotes relaxation and reduces symptoms of anxiety
Initial Treatment Period (Weeks 1-4): Dosage: Administer 400mcg (4 sprays) of nasal spray TB-500 twice a day
This peptide supports a wide range of health goals, including improved physical performance, sleep quality, energy levels, weight loss and management, cognitive function, and more
US$ 21.51
US$ 20.25
US$ 29.43
US$ 29.04
US$ 22.71
US$ 27.91
US$ 25.48
US$ 26.15
US$ 21.86
